These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 3698180

  • 1. Randomized crossover antiemetic study in cisplatin-treated patients. Comparison between high-dose i.v. metoclopramide and high-dose i.v. dexamethasone.
    Frustaci S, Grattoni E, Tumolo S, Crivellari D, Figoli F, Galligioni E, Veronesi A, Tirelli U, Grigoletto E.
    Cancer Chemother Pharmacol; 1986; 17(1):75-9. PubMed ID: 3698180
    [Abstract] [Full Text] [Related]

  • 2. High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.
    Strum SB, McDermed JE, Liponi DF.
    J Clin Oncol; 1985 Feb; 3(2):245-51. PubMed ID: 4038511
    [Abstract] [Full Text] [Related]

  • 3. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
    Shinkai T, Saijo N, Eguchi K, Sasaki Y, Tamura T, Tominaga K, Sakurai M, Sano T, Taito H, Takahashi H.
    Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
    [Abstract] [Full Text] [Related]

  • 4. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul 11; 340(8811):96-9. PubMed ID: 1352024
    [Abstract] [Full Text] [Related]

  • 5. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
    Malik I, Moid I, Khan Z, Hussain M.
    Am J Clin Oncol; 1999 Apr 11; 22(2):126-30. PubMed ID: 10199444
    [Abstract] [Full Text] [Related]

  • 6. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
    Roila F, Tonato M, Basurto C, Picciafuoco M, Bracarda S, Donati D, Malacarne P, Monici L, Di Costanzo F, Patoia L.
    J Clin Oncol; 1989 Nov 11; 7(11):1693-700. PubMed ID: 2681556
    [Abstract] [Full Text] [Related]

  • 7. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG.
    Semin Oncol; 1994 Oct 11; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [Abstract] [Full Text] [Related]

  • 8. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
    Shinkai T, Saijo N, Eguchi K, Sasaki Y, Tamura T, Fujiwara Y, Mae M, Fukuda M, Ohe Y, Sasaki S.
    Jpn J Clin Oncol; 1989 Mar 11; 19(1):40-4. PubMed ID: 2921817
    [Abstract] [Full Text] [Related]

  • 9. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A, Tripathi KD, Sharma M.
    Indian J Med Res; 2003 Jul 11; 118():33-41. PubMed ID: 14748464
    [Abstract] [Full Text] [Related]

  • 10. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
    Hainsworth J, Harvey W, Pendergrass K, Kasimis B, Oblon D, Monaghan G, Gandara D, Hesketh P, Khojasteh A, Harker G.
    J Clin Oncol; 1991 May 11; 9(5):721-8. PubMed ID: 1826739
    [Abstract] [Full Text] [Related]

  • 11. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
    Gilbert CJ, Ohly KV, Rosner G, Peters WP.
    Cancer; 1995 Dec 01; 76(11):2330-7. PubMed ID: 8635039
    [Abstract] [Full Text] [Related]

  • 12. Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
    González Barón M, Chacón JI, García Girón C, Ordóñez Gallego A, García de Paredes ML, Feliu J, Zamora P, Herranz C, Garrido P, Artal A.
    Acta Oncol; 1991 Dec 01; 30(5):623-7. PubMed ID: 1892680
    [Abstract] [Full Text] [Related]

  • 13. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
    Kris MG, Gralla RJ, Clark RA, Tyson LB, Fiore JJ, Kelsen DP, Groshen S.
    Cancer Treat Rep; 1985 Nov 01; 69(11):1257-62. PubMed ID: 3912039
    [Abstract] [Full Text] [Related]

  • 14. Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report.
    Mantovani G, Curreli L, Macciò A, Massa E, Massa D, Mulas C, Succu G, Contu P.
    Anticancer Res; 1999 Nov 01; 19(4C):3495-502. PubMed ID: 10629642
    [Abstract] [Full Text] [Related]

  • 15. A phase II antiemetic combination (COMD) for cisplatin-induced nausea and vomiting.
    Roila F, Basurto C, Minotti V, Ballatori E, Tonato M.
    Cancer Chemother Pharmacol; 1986 Nov 01; 18(1):88-9. PubMed ID: 3757163
    [Abstract] [Full Text] [Related]

  • 16. Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.
    Aapro MS, Plezia PM, Alberts DS, Graham V, Jones SE, Surwit EA, Moon TE.
    J Clin Oncol; 1984 May 01; 2(5):466-71. PubMed ID: 6539363
    [Abstract] [Full Text] [Related]

  • 17. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG, Gralla RJ, Tyson LB, Clark RA, Cirrincione C, Groshen S.
    J Clin Oncol; 1989 Jan 01; 7(1):108-14. PubMed ID: 2642536
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.